Table of Contents
- Trial overview
- Patient groups studied
- Trial design and phase
- Main outcomes being measured
- What the results may mean
Trial overview
The source data includes two authorised interventional studies involving Sodium Glycerophosphate-related nutrition support in surgical patients.[1][1] One study is titled “Route of nutrition and muscle wasting after oesophagectomy,” and the other is titled “Early versus postponed supplementary parenteral nutrition after major emergency abdominal surgery.”[1][1]
Both studies are Phase 3 trials, which means they are testing the approach in larger patient groups and focusing on real clinical results after surgery.[1][1]
Patient groups studied
One trial studies people after oesophagectomy, which is surgery to remove part or all of the food pipe.[1] The trial aims to understand how the route of nutrition affects cachexia, a term used for severe body wasting or loss of weight and muscle during illness.[1]
The second trial studies people after major emergency abdominal surgery, meaning urgent surgery in the abdomen.[1] This study compares early and postponed supplementary parenteral nutrition, which is extra nutrition given through a vein when regular feeding is not enough.[1]
The trial data does not give detailed inclusion or exclusion rules, so the main target groups are the surgical patients named in each study title and condition field.[1][1]
Trial design and phase
Both studies are listed as interventional, which means researchers assign a nutrition strategy and then measure the effect.[1][1] This is different from an observational study, where researchers only watch what happens without assigning treatment.[1][1]
The first trial has an enrollment of 38 participants, while the second trial plans to enroll 342 participants.[1][1] These numbers show that the studies are looking at both a smaller focused group and a larger group for comparison.[1][1]
Both studies are marked Authorised, which means they have been approved in the source record.[1][1]
Main outcomes being measured
The first trial measures the mean difference in muscle size using a CT-scan from before surgery to 10 days after surgery.[1] This outcome is meant to show whether the nutrition route affects muscle loss after oesophagectomy.[1]
The second trial measures the reduction in the rate of infectious complications during admission.[1] In simple terms, the study wants to know whether giving supplementary parenteral nutrition earlier or later changes the chance of infection while the patient is in hospital.[1]
What the results may mean
These trials are not designed to describe Sodium Glycerophosphate as a medicine in general; they are studying how nutrition support strategies perform in surgical recovery.[1][1] The main question is whether different nutrition routes or timing can help reduce muscle wasting or infections after major surgery.[1][1]
If the trials show benefit, the results could support better nutrition planning for patients recovering from oesophagectomy or major emergency abdominal surgery.[1][1]
